Comparison of lacosamide concentrations in cerebrospinal fluid and serum in patients with epilepsy
Author:
Affiliation:
1. Society for Epilepsy Research; Bielefeld Germany
2. Epilepsy Center Bethel; Bielefeld Germany
3. UCB Pharma; Monheim am Rhein Germany
Publisher
Wiley
Subject
Clinical Neurology,Neurology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/epi.13022/fullpdf
Reference13 articles.
1. UCB Pharma Vimpat ® (lacosamide tablets, injection, oral solution) [U.S. prescribing information] Smyrna UCB, Inc http://www.vimpat.com/pdf/vimpat_PI.pdf
2. UCB Pharma Vimpat ® (lacosamide) EMA summary of product characteristics http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/000863/WC500050338.pdf
3. Lacosamide: a review of preclinical properties;Beyreuther;CNS Drug Rev,2007
4. Tolerability, pharmacokinetics, and bioequivalence of the tablet and syrup formulations of lacosamide in plasma, saliva, and urine: saliva as a surrogate of pharmacokinetics in the central compartment;Cawello;Epilepsia,2013
5. Absorption, disposition, metabolic fate and elimination of the anti-epileptic drug lacosamide in humans: mass balance following intravenous and oral administration;Cawello;Eur J Drug Metab Pharmacokinet,2012
Cited by 27 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Interspecies Brain PBPK Modeling Platform to Predict Passive Transport through the Blood–Brain Barrier and Assess Target Site Disposition;Pharmaceutics;2024-02-04
2. Lacosamide dosing in patients receiving continuous renal replacement therapy;Journal of Intensive Care;2023-11-09
3. Efficacy and Safety of Five Broad-Spectrum Antiseizure Medications for Adjunctive Treatment of Refractory Epilepsy: A Systematic Review and Network Meta-analysis;CNS Drugs;2023-08-17
4. Analytical and Clinical Validation of Assays for Volumetric Absorptive Microsampling (VAMS) of Drugs in Different Blood Matrices: A Literature Review;Molecules;2023-08-14
5. Targeting adverse effects of antiseizure medication on offspring: current evidence and new strategies for safety;Expert Review of Neurotherapeutics;2023-02-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3